Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) seeks to track a multifactor index that measures mid-capitalization U.S. stocks selected and weighted based on multiple quality, value, momentum, and low volatility factors. This mid-cap equity ETF targets companies with market capitalizations between large and small-cap ranges, typically $2-10 billion.

How It Works

FLQM uses a rules-based, multifactor approach that screens mid-cap stocks across quality metrics (high profitability, low debt), value measures (low price ratios), momentum indicators (positive price trends), and low volatility characteristics. Selected stocks receive optimized weightings based on factor scores rather than market capitalization. The fund rebalances semi-annually to maintain factor exposures and adjust for changing company fundamentals and market conditions.

Key Features

  • Combines four investment factors in single ETF, eliminating need to purchase separate quality, value, momentum, and low-volatility funds
  • Targets mid-cap sweet spot offering higher growth potential than large-caps with less volatility than small-caps
  • Zero expense ratio makes it cost-competitive against traditional mid-cap index funds charging 0.05-0.15% annually

Risks

  • This ETF can lose value if multifactor strategies underperform simple market-cap indexing, which occurred during growth stock rallies in 2020-2021
  • Factor tilts may cause significant tracking error versus broad mid-cap indexes, potentially lagging by 5-10% in unfavorable market conditions
  • Mid-cap stocks typically decline 35-45% during bear markets and experience higher volatility than large-cap alternatives throughout market cycles

Who Should Own This

Best suited as a satellite holding (10-25% of equity allocation) for investors with 3-7 year time horizons seeking factor-based mid-cap exposure. Medium-to-high risk tolerance required due to factor concentration and mid-cap volatility. Appeals to tactical investors believing multifactor approaches can outperform cap-weighted indexing over full market cycles.